These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37313154)

  • 1. Key genes involved with prognosis were identified in lung adenocarcinoma by integrated bioinformatics analysis.
    Song H; Wu J; Liu W; Cai K; Xie Z; Liu Y; Huang J; Gan S; Xiong Y; Sun Y
    Heliyon; 2023 Jun; 9(6):e16789. PubMed ID: 37313154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics.
    Cai K; Xie Z; Liu Y; Wu J; Song H; Liu W; Wang X; Xiong Y; Gan S; Sun Y
    Biomed Res Int; 2023; 2023():2152432. PubMed ID: 36714024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core genes in lung adenocarcinoma identified by integrated bioinformatic analysis.
    Yang L; Yu Q; Zhu Y; Ali Mallah M; Wang W; Feng F; Zhang Q
    Int J Environ Health Res; 2023 Mar; 33(3):243-257. PubMed ID: 34961365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKMYT1 as a Potential Target to Improve the Radiosensitivity of Lung Adenocarcinoma.
    Long HP; Liu JQ; Yu YY; Qiao Q; Li G
    Front Genet; 2020; 11():376. PubMed ID: 32411179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma.
    Xu Z; Wang S; Ren Z; Gao X; Xu L; Zhang S; Ren B
    World J Surg Oncol; 2022 Mar; 20(1):99. PubMed ID: 35354488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated bioinformatics analysis of microarray data from the GEO database to identify the candidate genes linked to poor prognosis in lung adenocarcinoma.
    Liu X; Li L; Xie X; Zhuang D; Hu C
    Technol Health Care; 2023; 31(2):579-592. PubMed ID: 36336945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
    Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
    Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-SMC condensin I complex subunit H (NCAPH), a regulator of cell cycle, predicts poor prognosis in lung adenocarcinoma patients: a study mainly based on TCGA and GEO database.
    Zhou W; Hu J; Zhao J
    Transl Cancer Res; 2020 Dec; 9(12):7572-7587. PubMed ID: 35117357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The EMT-Related Genes GALNT3 and OAS1 are Associated with Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma.
    Luo D; Fang M; Shao L; Wang J; Liang Y; Chen M; Gui X; Yan J; Wang W; Yu L; Fan X; Wu Q
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):271. PubMed ID: 37919050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key genes and biological pathways in lung adenocarcinoma by integrated bioinformatics analysis.
    Zhang L; Liu Y; Zhuang JG; Guo J; Li YT; Dong Y; Song G
    World J Clin Cases; 2023 Aug; 11(23):5504-5518. PubMed ID: 37637684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential key molecular biomarkers in lung adenocarcinoma by bioinformatics analysis.
    Guo P; Xu T; Jiang Y; Shen W
    Transl Cancer Res; 2022 Jan; 11(1):227-241. PubMed ID: 35261899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZC3H12D is a prognostic biomarker associated with immune cell infiltration in lung adenocarcinoma.
    Gong W; Dai W; Wei H; Chen Y; Zheng Z
    Transl Cancer Res; 2020 Oct; 9(10):6128-6142. PubMed ID: 35117224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
    Fan K; Zhang BH; Han D; Sun YC
    BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNRPD1/E/F/G Serve as Potential Prognostic Biomarkers in Lung Adenocarcinoma.
    Liu G; Li F; Chen M; Luo Y; Dai Y; Hou P
    Front Genet; 2022; 13():813285. PubMed ID: 35356432
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening of Key Prognosis Genes of Lung Adenocarcinoma Based on Expression Analysis on TCGA Database.
    Shen Y; Tang X; Zhou X; Yi Y; Qiu Y; Xu J; Tian X
    J Oncol; 2022; 2022():4435092. PubMed ID: 36600965
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX
    Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis.
    Liu TT; Li R; Huo C; Li JP; Yao J; Ji XL; Qu YQ
    Front Cell Dev Biol; 2021; 9():682002. PubMed ID: 34409029
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Wu C; Dong B; Huang L; Liu Y; Ye G; Li S; Qi Y
    Front Oncol; 2021; 11():754290. PubMed ID: 34745988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
    Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification key genes, key miRNAs and key transcription factors of lung adenocarcinoma.
    Li J; Li Z; Zhao S; Song Y; Si L; Wang X
    J Thorac Dis; 2020 May; 12(5):1917-1933. PubMed ID: 32642095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.